Dow Today: Merck (MRK) Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 34 points (+0.2%) at 16,463 as of Wednesday, Aug 6, 2014, 12:36 p.m. ET. During this time, 178.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 305.3 million. The NYSE advances/declines ratio sits at 2,014 issues advancing vs. 970 declining with 140 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is Merck (NYSE: MRK), which is lagging the broader index with a five-cent decline to $55.98. Volume for Merck currently sits at 7.6 million shares traded vs. an average daily trading volume of 8.2 million shares.

Merck has a market cap of $166.75 billion and is part of the health care sector and drugs industry. Shares are up 14% year-to-date as of Tuesday's close. The stock's dividend yield sits at 3.1%.

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.

TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, solid stock price performance, growth in earnings per share and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

If you liked this article you might like

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Why You Keep Cash on Hand; No Downside Conviction -- Jim Cramer's Top Thoughts